Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion type Assertion NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_head.
- NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion wasGeneratedBy ECO_0000203 NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_provenance.
- NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion wasDerivedFrom befree-2016 NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_provenance.
- NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion SIO_000772 22123319 NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_provenance.
- NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion evidence source_evidence_literature NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_provenance.
- NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_assertion description "[Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in two phase III trials of patients with advanced melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP942351.RADW-R8IjqeZ0hiHT1YcrqIIeiKjpQIBwykHKeuTQsd6Q130_provenance.